RxDoctor Payments Data

Nicholas Ting, MD

Orthopaedic Surgery · Leawood, KSNPI 1659698561

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (41.5%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Ortho Development Corporation at 49.5% of the total.

$23,353in general payments, 2019–2025

Across 110 payments — averaging $212.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ortho Development Corporation$12K
  • Stryker$4K
  • Encore Medical, LP$2K
  • Think Surgical, Inc.$2K
  • Medical Device Business Services, Inc.$2K
  • Smith+Nephew$1K
  • plus $389 from 7 others

What the payments were for

  • Consulting fees$9,68041%
  • Speaking & faculty fees$1,5006%
  • Travel & lodging$9,39140%
  • Food & beverage$2,78212%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,353 in reported general payments places this provider in the 80th percentile of 197 orthopaedic surgery providers in Kansas.

See all orthopaedic surgery providers in Kansas

Medicare billing

Part B allowed, 2024
$353,437
Medicare patients
454
Services billed
13,368

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Amoxicillin125$285
Celecoxib16$267
Clindamycin Hcl24$117
Tramadol Hcl16$93
Meloxicam23$50

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Leawood

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →